Explore how clinician communication shapes patient beliefs about generic drugs. Learn how to overcome skepticism, manage the nocebo effect, and improve adherence with proven strategies.
DetailsPharmacokinetic studies are the primary method used to prove generic drugs work like brand-name versions. But they're not perfect. Learn how Cmax and AUC measurements work, why regulators are moving beyond them, and what this means for your medication safety.
DetailsCombination products like multi-drug pills, inhalers, and topical creams face unique bioequivalence challenges that delay generic access. Learn why testing them is harder, costlier, and more complex than single-drug generics.
DetailsBioavailability studies ensure generic drugs work like brand-name versions by measuring how much and how fast the active ingredient enters the bloodstream. The FDA uses AUC and Cmax data to confirm equivalence within an 80-125% range.
DetailsLearn the real differences between generic rosuvastatin and brand-name Crestor, covering efficacy, safety, price, and when each option is best for you.
Details